Effects of recombinant human granulocyte colony-stimulating factor on the hematologic recovery and survival of irradiated mice.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Blood

• Publication date

  1990-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V76.3.445.445PMID 1696145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I study of recombinant human tumor necrosis factor

  2004cited by this paper
• Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation.

  1989cited by this paper
• Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.

  1989cited by this paper
• Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.

  1988cited by this paper
• Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

  1988cited by this paper
• Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor.

  1988cited by this paper
• Cytokines in therapy of radiation injury.

  1988cited by this paper
• Clinical toxicity of interferons in cancer patients: a review.

  1986cited by this paper
• Recombinant human granulocyte colony stimulating factor: molecular and biological characterization.

  1986cited by this paper
• An update on human interleukin-1: From molecular biology to clinical relevance

  1985cited by this paper
• Effect of thrombocyte-rich plasma on x-ray induced bone marrow death in mice.

  1973cited by this paper
• A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

  1961cited by this paper

• Radiation emergency medical countermeasures: Current formulary, identified gaps, and future approaches

  2025cites this paper
• CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice

  2020cites this paper
• Radiosensitivity: Gender and Order of Administration of G-CSF, An Experimental Study in Mice

  2019cites this paper
• PEGylated IL‐11 (BBT‐059): A Novel Radiation Countermeasure for Hematopoietic Acute Radiation Syndrome

  2018cites this paper
• A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures

  2017cites this paper
• Radioprotective ef fi cacy of delta-tocotrienol , a vitamin E isoform , is mediated through granulocyte colony-stimulating factor

  2017cites this paper
• Impact of Abbreviated Filgrastim Schedule on Survival and Hematopoietic Recovery after Irradiation in Four Mouse Strains with Different Radiosensitivity

  2017cites this paper
• Granulocyte colony-stimulating factor exacerbates hematopoietic stem cell injury after irradiation

  2015cites this paper
• Vitamin E Analogs as Radiation Response Modifiers

  2015cites this paper
• Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman Primates.

  2015cites this paper
• Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review.

  2015cites this paper
• Cellular Therapies in Post-radiation Syndrome

  2015cites this paper
• Thrombomodulin Contributes to Gamma Tocotrienol-Mediated Lethality Protection and Hematopoietic Cell Recovery in Irradiated Mice

  2015cites this paper
• Filgrastim for the treatment of hematopoietic acute radiation syndrome.

  2015cites this paper
• Radiation countermeasure agents: an update (2011 – 2014)

  2014cites this paper
• Radioprotective efficacy of delta-tocotrienol, a vitamin E isoform, is mediated through granulocyte colony-stimulating factor.

  2014cites this paper
• The Ability of Filgrastim to Mitigate Mortality Following LD50/60 Total-body Irradiation Is Administration Time-Dependent

  2014cites this paper
• Mitigating effects of hUCB-MSCs on the hematopoietic syndrome resulting from total body irradiation.

  2013cites this paper
• recombinant granulocyte-macrophage CSF, and their combination recombinant granulocyte colony-stimulating factor (G-CSF), Comparative analysis of the in vivo radioprotective effects of

  2013cites this paper
• Filgrastim Improves Survival in Lethally Irradiated Nonhuman Primates

  2013cites this paper
• Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures

  2013cites this paper
• Establishing a Murine Model of the Hematopoietic Syndrome of the Acute Radiation Syndrome

  2012cites this paper
• Pegfilgrastim Administered in an Abbreviated Schedule, Significantly Improved Neutrophil Recovery after High-Dose Radiation-Induced Myelosuppression in Rhesus Macaques

  2012cites this paper
• A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute

  2012cites this paper
• Effects of recombinant human granulocyte colony-stimulating factor on central and peripheral T lymphocyte reconstitution after sublethal irradiation in mice

  2012cites this paper
• Radiological and Nuclear Countermeasures Chapter 11 PERSPECTIVES IN RADIOLOGICAL AND NUCLEAR COUNTERMEASURES

  2012cites this paper
• 5-Androstene-3β,17β-diol promotes recovery of immature hematopoietic cells following myelosuppressive radiation and synergizes with thrombopoietin.

  2012cites this paper
• Recombinant Human G-CSF Enhances Recovery and Improves Survival from Severe Radiation-Induced Myelosuppression

  2012cites this paper
• Mitigation of ionizing radiation-induced bone marrow suppression by p38 inhibition and G-CSF administration.

  2011cites this paper
• The Proceedings of the 3rd International Symposium on Radiation Emergency Medicine at Hirosaki University

  2011cites this paper
• A TPO Receptor Agonist, ALXN4100TPO, Mitigates Radiation-Induced Lethality and Stimulates Hematopoiesis in CD2F1 Mice

  2011cites this paper
• RhG-CSF improves radiation-induced myelosuppression and survival in the canine exposed to fission neutron irradiation.

  2011cites this paper
• Preliminary clinical findings on NEUMUNE as a potential treatment for acute radiation syndrome

  2010cites this paper
• Growth Hormone Mitigates against Lethal Irradiation and Enhances Hematologic and Immune Recovery in Mice and Nonhuman Primates

  2010influential citation
• Activation of adenosine A3 receptors supports hematopoiesis-stimulating effects of granulocyte colony-stimulating factor in sublethally irradiated mice

  2010cites this paper
• An anti-apoptotic peptide improves survival in lethal total body irradiation.

  2009cites this paper
• History and development of radiation-protective agents

  2009cites this paper
• Reply to Hérodin and Drouet: "Myeloprotection Following Cytotoxic Damage: The Sooner the Better"

  2008cites this paper
• Inhibition of Cyclooxygenase 2 in Mice Increases Production of G-CSF and Induces Radioprotection

  2008cites this paper
• Anti-apoptotic peptides protect against radiation-induced cell death.

  2007cites this paper
• Evaluation of the synergistic effect of danazol and radiation exposure on some biochemical functions in female albino rats.

  2007cites this paper
• Acute radiation injury: contingency planning for triage, supportive care, and transplantation.

  2006cites this paper
• Vascular endothelial cells produce soluble factors that mediate the recovery of human hematopoietic stem cells after radiation injury.

  2006cites this paper
• The mobilization of hematopoietic progenitors to peripheral blood is predictive of the hematopoietic syndrome after total or partial body irradiation of mice.

  2006cites this paper
• DEFINING THE FULL THERAPEUTIC POTENTIAL OF RECOMBINANT GROWTH FACTORS IN THE POST RADIATION-ACCIDENT ENVIRONMENT: THE EFFECT OF SUPPORTIVE CARE PLUS ADMINISTRATION OF G-CSF

  2005cites this paper
• Hematopoietic Growth Factors

  2004cites this paper
• Increase in Endogenous Spleen Colonies without Recovery of Blood Cell Counts in Radioadaptive Survival Response in C57BL/6 Mice

  2004cites this paper
• Drugs elevating extracellular adenosine promote regeneration of haematopoietic progenitor cells in severely myelosuppressed mice: their comparison and joint effects with the granulocyte colony‐stimulating factor

  2002cites this paper
• Application thérapeutique de l'IL-4 dans un modèle de souris irradiées corps entier à dose létale

  2002cites this paper
• Rescue of Lethally Irradiated Mice from Hematopoietic Death by Pre-exposure to 0.5 Gy X Rays without Recovery from Peripheral Blood Cell Depletion and its Modification by OK432

  2001cites this paper
• Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality.

  2001cites this paper
• OK-432 reduces mortality and bacterial translocation in irradiated and granulocyte-colony stimulating factor (G-CSF)-treated mice.

  2001cites this paper
• Selective stimulation of G‐CSF gene expression in macrophages by a stimulatory monoclonal antibody as detected by a luciferase reporter gene assay

  2000cites this paper
• Interleukin 4 promotes survival of lethally irradiated mice in the absence of hematopoietic efficacy.

  1999cites this paper
• Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation.

  1999cites this paper
• Alglucerase enzyme replacement therapy used safely and effectively throughout the whole pregnancy of a Gaucher disease patient.

  1998cites this paper
• Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.

  1998cites this paper
• Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission.

  1998cites this paper
• Granulocyte colony-stimulating factor administered as a single intraperitoneal injection modifies the lethal dose95/30 in irradiated B6D2F1 mice.

  1998cites this paper
• A specific stimulator of granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in the mouse.

  1997cites this paper
• Effect of continuous intravenous administration of high-dose G-CSF on hematologic recovery following autologous purged bone marrow transplantation.

  1997cites this paper
• Effect in supralethally irradiated rats of granulocyte colony-stimulating factor and lisofylline on hematopoietic reconstitution by syngeneic bone marrow or whole organ passenger leukocytes.

  1997cites this paper
• Serum levels of G-CSF, IL-3, IL-6 and GM-CSF after a single intraperitoneal dose of rhG-CSF in lethally irradiated B6D2F1 mice.

  1997cites this paper
• Efficacy of Mpl Ligands and Other Thrombopoietic Cytokines in Animal Models

  1997cites this paper
• Practical and theoretical issues in 1993 concerning radiation effects on the growth of normal and neoplastic hematopoietic cells

  1997cites this paper
• Cutaneous reactions to recombinant cytokine therapy.

  1996cites this paper
• Comparison of two strategies for the treatment of radiogenic leukopenia using granulocyte colony stimulating factor.

  1996cites this paper
• Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.

  1996cites this paper
• Tumor necrosis factor and interleukin-1 synergize with irradiation in expression of GM-CSF gene in human fibroblasts.

  1995cites this paper
• Improvement of efficacy of antitumor agents by conagenin.

  1995cites this paper
• Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation

  1994cites this paper
• Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.

  1994cites this paper
• Effect of human recombinant granulocyte colony-stimulating factor on induction of myeloid leukemias by X-irradiation in mice.

  1993cites this paper
• A single dose of granulocyte colony-stimulating factor modifies radiation-induced death in B6D2F1 mice.

  1993cites this paper
• Effects of Recombinant Interleukin‐3 and Recombinant Interleukin‐6 on Radiation Survival of Normal Human Bone Marrow Progenitor Cells

  1993cites this paper
• Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function.

  1993cites this paper
• Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapy.

  1993cites this paper
• Radionuclide therapy of bone metastases: prospects for enhancement of therapeutic efficacy.

  1993cites this paper
• Effect of recombinant human granulocyte colony-stimulating factor on survival in lethally irradiated mice.

  1992cites this paper
• Radioprotective effects of serum thymic factor in mice.

  1992cites this paper
• Effects of hematopoietic growth factors on chemotherapy-induced myelosuppression.

  1992cites this paper
• Radioreductive effect of bestatin (Ubenimex) in BALB/c mice.

  1992cites this paper
• Pharmaceutical applications

  1991cites this paper
• Recombinant Granulocyte Colony-Stimulating Factor (rG-CSF)

  1991cites this paper
• Granulocyte colony-stimulating factor and its receptor.

  1991cites this paper
• The Florey Lecture, 1991. The colony-stimulating factors: discovery to clinical use.

  1991cites this paper
• Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination.

  1991cites this paper
• Autotransplants in leukemia: current state, future progress.

  1991cites this paper
• The Current Status of Myeloid Growth Factor Therapy

  1991cites this paper
• Use of hematopoietic growth factors in radiation accidents.

  1990cites this paper